Profile
Andrew P.
Rasdal served as President, Chief Executive Officer & Director at Obalon Therapeutics, Inc. from 2020 to 2021.
Prior to that, he was President, Chief Executive Officer & Director at DexCom, Inc. from 2002 to 2007 and President-Vascular & Senior Vice President at Medtronic, Inc. from 1999 to 2002.
He also served as Vice President-Marketing at Arterial Vascular Engineering, Inc. from 1997 to 1999 and President at Vascular Science, Inc. Mr. Rasdal holds an MBA from Northwestern University, an undergraduate degree from San Jose State University, and a graduate degree from Kellogg School of Management.
Former positions of Andrew P. Rasdal
| Companies | Position | End |
|---|---|---|
| RESHAPE LIFESCIENCES INC. | Chief Executive Officer | 2021-06-14 |
| DEXCOM, INC. | Chief Executive Officer | 2007-05-31 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 2001-12-31 |
Arterial Vascular Engineering, Inc.
 Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Sales & Marketing | 1998-12-31 |
Vascular Science, Inc.
 Vascular Science, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The private company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million. | President | - |
Training of Andrew P. Rasdal
| Northwestern University | Masters Business Admin |
| San Jose State University | Undergraduate Degree |
| Kellogg School of Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DEXCOM, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Vascular Science, Inc.
Vascular Science, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The private company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million. | Health Technology |
- Stock Market
- Insiders
- Andrew P. Rasdal
